Moderate

Adrenal incidentaloma

incidentaloma · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

An adrenal mass found unexpectedly on imaging done for another reason. Evaluation focuses on excluding hormone excess and malignancy, since most are benign non-functioning adenomas.

Red flags

  • Size >4 cm or rapid growth
  • Unenhanced attenuation >10 HU with poor washout (malignancy)
  • Biochemical phaeochromocytoma
  • Virilisation/feminisation (adrenocortical carcinoma)
  • Bilateral masses with adrenal insufficiency

Assessment

Differential diagnosis

  • Non-functioning adenoma
  • Cortisol-secreting adenoma (including mild autonomous secretion)
  • Phaeochromocytoma
  • Aldosterone-producing adenoma
  • Adrenocortical carcinoma
  • Metastasis
  • Myelolipoma

Investigations

  • Dedicated adrenal CT with unenhanced Hounsfield units and washout
  • 1 mg overnight dexamethasone suppression test
  • Plasma/24h urinary metanephrines
  • Aldosterone-to-renin ratio if hypertensive/hypokalaemic
  • Androgens/steroid precursors if virilisation or carcinoma suspected

Management

  • Characterise the mass on imaging: size, lipid content (HU) and washout
  • Screen all patients for phaeochromocytoma and autonomous cortisol secretion
  • Screen hypertensive/hypokalaemic patients for primary aldosteronism
  • Interpret dexamethasone test: cortisol >50 nmol/L indicates possible autonomous secretion
  • Refer indeterminate (>10 HU, poor washout) or large (>4 cm) lesions for surgical assessment
  • Resect confirmed functioning tumours and suspected adrenocortical carcinoma
  • For mild autonomous cortisol secretion, manage comorbidities and consider surgery case by case
  • Follow benign non-functioning lesions with limited interval imaging/biochemistry
  • Give perioperative steroid cover after removal of cortisol-secreting tumours

Drugs & doses

Alpha-blockade (e.g. phenoxybenzamine/doxazosin) before any phaeochromocytoma surgery
Hydrocortisone perioperative cover after resection of cortisol-secreting adenoma
Mineralocorticoid receptor antagonist if aldosterone excess confirmed and inoperable

Disposition

Investigate via endocrinology; refer functioning, large or indeterminate lesions to adrenal surgery and arrange structured follow-up for benign masses.

Complications & pitfalls

  • Undetected phaeochromocytoma crisis during surgery
  • Missed cortisol/aldosterone excess with cardiometabolic harm
  • Adrenocortical carcinoma progression if resection delayed
  • Adrenal insufficiency after unilateral adrenalectomy for autonomous cortisol

Exam pearls

  • Every incidentaloma needs metanephrines and a dexamethasone suppression test, even if asymptomatic
  • A homogeneous lesion <10 HU is almost always a benign adenoma
  • Mild autonomous cortisol secretion is common and linked to hypertension, diabetes and fractures
  • Never biopsy an adrenal mass until phaeochromocytoma is excluded

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.